Niraparib

ATC L01XK02 · 10 markets · 33 records

Niraparib 10 markets · 33 records Forms

US 5 records · 4 strengths

100 mgtabletAKEEGA+1ZEJULA also in GB·CA·ES +3
50 mgtabletAKEEGA also in GB·CA·ES
200 mgtabletZEJULA also in SG
300 mgtabletZEJULA

GB 5 records · 3 strengths

100 mgtabletAKEEGA+1ZEJULA also in US·CA·ES +3
50 mgtabletAKEEGA also in US·CA·ES
100 mgcapsuleZEJULA

HK 4 records · 1 strengths

Records without a stated strength · 1 AKEEGA、ZEJULA

CA 3 records · 2 strengths

100 mgtabletAKEEGA+1ZEJULA also in US·GB·ES +3
50 mgtabletAKEEGA also in US·GB·ES

ES 3 records · 2 strengths

100 mgtabletAKEEGA+1ZEJULA also in US·GB·CA +3
50 mgtabletAKEEGA also in US·GB·CA

TW 3 records · 2 strengths

100 mgtabletZEJULA+1截永樂錠100毫克 also in US·GB·CA +3

Records without a stated strength · 1 AKEEGA、澤截膜衣錠100/500毫克、澤截膜衣錠50/500毫克

AU 2 records · 1 strengths

100 mgtabletZEJULA also in US·GB·CA +3

SG 2 records · 2 strengths

100 mgtabletZEJULA also in US·GB·CA +3
200 mgtabletZEJULA also in US

EU 2 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 AKEEGA、ZEJULA

MX 1 records · 1 strengths

Records without a stated strength · 1 AKEEGA

Side-by-side table

Strength / form / release	US	GB	CA	AU	SG	ES	MX	TW	HK	EU
100 mg tablet	AKEEGA ZEJULA	AKEEGA ZEJULA	AKEEGA ZEJULA	ZEJULA	ZEJULA	AKEEGA ZEJULA	not recorded	ZEJULA 截永樂錠100毫克	not recorded	not recorded
50 mg tablet	AKEEGA	AKEEGA	AKEEGA	not recorded	not recorded	AKEEGA	not recorded	not recorded	not recorded	not recorded
200 mg tablet	ZEJULA	not recorded	not recorded	not recorded	ZEJULA	not recorded	not recorded	not recorded	not recorded	not recorded
300 mg tablet	ZEJULA	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
100 mg capsule	not recorded	ZEJULA	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
not disclosed tablet	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	AKEEGA	AKEEGA 澤截膜衣錠100/500毫克澤截膜衣錠50/500毫克	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	AKEEGA ZEJULA	AKEEGA ZEJULA

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

1 more strength/form rows are recorded only in HK · EU and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en HK · EU que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 HK · EU 有记录（未在本表显示）。另有 1 個規格/劑型僅在 HK · EU 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.